Business Divestitures and Assets and Liabilities Held for Sale - Fair Value of Sale Consideration Received (Details) - Disposal Group, Held-for-sale or Disposed of by Sale, Not Discontinued Operations - USD ($) $ in Millions	May 09, 2025	May 01, 2025
Pharma Solutions
Income Statement, Balance Sheet and Additional Disclosures by Disposal Groups, Including Discontinued Operations [Line Items]
Cash proceeds from the buyer		$ 2,564
Amount held in escrow		17
Earnout consideration		100
Direct costs to sell		(30)
Fair value of sale consideration		$ 2,651
Nitrocellulose
Income Statement, Balance Sheet and Additional Disclosures by Disposal Groups, Including Discontinued Operations [Line Items]
Cash proceeds from the buyer	$ 161
Direct costs to sell	(3)
Fair value of sale consideration	$ 158